시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 정맥주사 철분 - 시장 규모, 점유율, 성장 분석 : 제품유형별, 적응증별, 유통채널별, 지역별 산업예측(2025-2032년)
Intravenous Iron Drugs Market Size, Share, Growth Analysis, By Product Type (Iron Dextran, Iron Sucrose), By Indication (Chronic Kidney Disease, Inflammatory Bowel Disease), By Distribution Channel, By Region - Industry Forecast 2025-2032
상품코드 : 1623729
리서치사 : SkyQuest
발행일 : 2024년 12월
페이지 정보 : 영문 219 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,657,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,957,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,258,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

정맥주사 철분 시장 규모는 2023년 32억 달러로 평가되었고, 2024년 34억 7,000만 달러에서 2032년에는 66억 1,000만 달러로 성장해 예측기간(2025-2032년) CAGR 8.4%로 성장할 전망입니다.

세계의 정맥주사 철분시장은 인구의 상당 부분이 이환되고 있는 철결핍성 빈혈의 이환율의 상승을 주인으로 하여 현저한 성장을 이루고 있습니다. 정맥 내 철분 요법은 경구 보충제를 대체하는 효율적인 선택을 제공하고 신속한 구제 및 환자 결과 개선을 보장합니다. 이를 위해 연구개발에 많은 투자를 하고 있으며 제품 라인과 시장 도달범위를 확대하기 위해 전략적으로 협력하고 있습니다.

목차

소개

조사 방법

주요 요약

시장 역학과 전망

주요 시장 인사이트

정맥주사 철분 시장 규모 : 제품 유형별

정맥주사 철분 시장 규모 : 적응증별

정맥주사 철분 시장 규모 : 유통채널별

정맥주사 철분시장 규모

경쟁 정보

주요 기업 프로파일

결론과 권장사항

JHS
영문 목차

영문목차

Intravenous Iron Drugs Market size was valued at USD 3.2 Billion in 2023 and is poised to grow from USD 3.47 Billion in 2024 to USD 6.61 Billion by 2032, growing at a CAGR of 8.4% during the forecast period (2025-2032).

The global intravenous iron drugs market is witnessing significant growth, primarily driven by the rising incidence of iron deficiency anemia, which affects a considerable portion of the population. This condition leads to decreased oxygen-carrying capacity, resulting in symptoms like fatigue and cognitive impairment. The aging demographic further fuels market demand, as older adults are more prone to iron deficiency due to factors such as dietary limitations and chronic illnesses. Intravenous iron therapy provides an efficient alternative to oral supplements, ensuring quicker relief and better patient outcomes. Market players are investing heavily in research and development to create innovative formulations and enhance safety, collaborating strategically to broaden their product lines and market reach. As awareness and demand increase, the market is poised for continued expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Intravenous Iron Drugs market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Intravenous Iron Drugs Market Segmental Analysis

Global Intravenous Iron Drugs Market is segmented by product type, indication, distribution channel and region. Based on product type, the market is segmented into Iron Dextran, Iron Sucrose, Ferric Carboxymaltose, and Other Product Types. Based on indication, the market is segmented into Chronic Kidney Disease, Inflammatory Bowel Disease, Cancer and Other Diseases. Based on distribution channel, the market is segmented into hospital pharmacy, retail pharmacy and online pharmacy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Intravenous Iron Drugs Market

The intravenous iron drugs market is significantly driven by the rising incidence of iron deficiency anemia globally. This condition is particularly prevalent among specific groups, including pregnant women, women of childbearing age, and individuals suffering from chronic illnesses. As awareness regarding the serious implications of iron deficiency continues to grow, coupled with the proven efficacy of intravenous iron therapies in effectively addressing this issue, there has been an upsurge in demand for these treatments. This heightened recognition and the ongoing need for effective solutions to combat iron deficiency anemia are key factors propelling the expansion of the intravenous iron drugs market.

Restraints in the Intravenous Iron Drugs Market

One significant restraint affecting the intravenous iron drugs market is the potential for adverse reactions or side effects during administration. Although these drugs are largely regarded as safe, the possibility of hypersensitivity reactions and infusion-related complications exists, including allergic responses, hypotension, and anaphylaxis. The fear of these adverse events may dissuade both healthcare professionals and patients from opting for intravenous iron therapy, thus restricting market growth. To address this challenge, it is crucial for manufacturers and healthcare providers to implement stringent patient selection criteria, effective monitoring, and careful administration protocols, all aimed at reducing the risk of complications and ensuring patient safety.

Market Trends of the Intravenous Iron Drugs Market

The intravenous iron drugs market is witnessing a significant trend towards innovation, characterized by the development of enhanced iron formulations designed to improve safety, efficacy, and patient convenience. Pharmaceutical companies are heavily investing in research to create advanced intravenous therapies that mitigate the drawbacks of traditional iron supplements, focusing on features such as extended dosing intervals, better tolerability, and minimized hypersensitivity risks. This shift not only enhances patient compliance but also marks a commitment to improving overall treatment outcomes. The ongoing push for novel formulations underscores a growing emphasis on patient-centric care within the intravenous iron drugs market, driving its growth and evolution.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Intravenous Iron Drugs Market Size by Product Type & CAGR (2025-2032)

Global Intravenous Iron Drugs Market Size by Indication & CAGR (2025-2032)

Global Intravenous Iron Drugs Market Size by Distribution Channel & CAGR (2025-2032)

Global Intravenous Iron Drugs Market Size & CAGR (2025-2032)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기